Oslo, Norway, March 14, 2023: Photocure ASA (OSE: PHO), the Bladder Cancer
Company, announces its participation in the congress, and two abstract
presentations at the European Association of Urology congress (EAU) in Milan,
Italy, highlighting the benefits of Blue Light Cystoscopy (BLC[®]) in Bladder
Cancer management.

The EAU annual meeting is one of the largest international meetings in the
urology calendar, showcasing the latest and most relevant knowledge in this area
of patient care. This year's event was held on March 10 -13, 2023 and attracted
urologists from all over the world. In addition to an active presence & support
for the event, Photocure will also be making bladder cancer session highlights
available post event by means of video interviews with the presenters of these
sessions. This initiative is supported by two of the leading names in Bladder
Cancer in Europe, Prof. M. Rouprêt, APHP, Sorbonne University Paris, France and
Prof. P. Gontero, Division of Urology, University of Studies of Torino, Italy.

In addition to this activity, two abstract presentations were presented as part
of the EAU scientific program that feature the blue light cystoscopy procedure:

Immunological changes following blue light cystoscopy with hexaminolevulinate in
bladder cancer (A0431 - Sunday 10:45)
The project conducted at Department of Molecular Medicine, Aarhus University
Hospital, Denmark, presents results from a pilot study of bladder cancer
patients, showing that blue light cystoscopy with Hexaminolevulinate (HAL)
during TURBT* may influence the immune cell composition and tumor
microenvironment. Preliminary findings suggest that BLC-guided TURBT changes the
expression of immune cells of both the adaptive and innate immune system
compared to WLC-guided TURBT. Further studies are required to validate the
clinical impact of these observations.

Read the abstract: https://resource-centre.uroweb.org/resource
-centre/EAU23/248125/Abstract

Blue Light Cystoscopy Delays Time to Recurrence in Non-Muscle Invasive Bladder
Cancer Patients Treated in a Real-World Setting (A0710 - Sunday 15:45)
Real-world data taken from the Blue Light Cystoscopy with Cysview[®] Registry
(Clinicaltrials.gov